Skip to main content
Clinical Trials/NL-OMON30087
NL-OMON30087Not yet recruitingNot Applicable

Algorithm verification STudy with an External Reveal (Investigationel Xt) - ASTERIX

Vitatron0 sites230 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
230

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Patient is willing to wear two external recording devices for a 48 hour period;
  • Patient is willing to give his/her informed consent;
  • Patient fulfills at least one of the following:
  • - Patient has atrial fibrillation or flutter with an indication for pharmacological
  • cardioversion;
  • - Patient has atrial fibrillation or flutter with an indication for electrical
  • cardioversion;
  • - Patient is scheduled for cardiac valve surgery or has undergone cardiac valve
  • surgery maximally 2 days previously;
  • - Ambulatory patient who will undergo pulmonary vein ablation or atrial flutter
  • - Ambulatory patient who has undergone pulmonary vein ablation or atrial
  • flutter ablation at least two months previously, with currently suspected
  • recurrence of atrial fibrillation or flutter;
  • - Ambulatory patient with suspected paroxysmal atrial fibrillation or other atrial
  • tachyarrhythmia.

Exclusion Criteria

  • Patient has an implanted pacemaker or ICD
  • Patient has an allergy against adhesive ECG electrodes
  • The study will interfere with a therapeutic or diagnostic procedure which is
  • planned or expected within the 48 hour study period
  • Patient is a minor, legally incompetent, or does not meet other local
  • requirements for participation in a clinical study

Investigators

Sponsor
Vitatron

Similar Trials